HOPE TINSLEY: Open Payments
NPI 1023738085 · FARMINGTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 14 payments from 10 companies in 2025. Trend: 2023 $207 · 2024 $314 · 2025 $272
Food & beverage: $272
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $79 |
| PFIZER INC. | 2 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| KYOWA KIRIN, INC. | 1 | $20 |
| Endo USA, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VRAYLAR, NURTEC ODT, QULIPTA, JOURNAVX, JARDIANCE, CRYSVITA, XIAFLEX, Veozah.
Industry payments across UT — which companies pay providers there.
